Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

被引:0
|
作者
Robert S. Ames
Henry M. Sarau
Johathan K. Chambers
Robert N. Willette
Nambi V. Aiyar
Anne M. Romanic
Calvert S. Louden
James J. Foley
Charles F. Sauermelch
Robert W. Coatney
Zhaohui Ao
Jyoti Disa
Stephen D. Holmes
Jeffrey M. Stadel
John D. Martin
Wu-Schyong Liu
George I. Glover
Shelagh Wilson
Dean E. McNulty
Catherine E. Ellis
Nabil A. Elshourbagy
Usman Shabon
John J. Trill
Douglas W. P. Hay
Eliot H. Ohlstein
Derk J. Bergsma
Stephen A. Douglas
机构
[1] Departments of Molecular Biology,
[2] Departments of Pulmonary and Cardiovascular Pharmacology,undefined
[3] ,undefined
[4] Departments of Functional Gene Analysis,undefined
[5] Departments of Pathology,undefined
[6] Laboratory Animal Sciences,undefined
[7] Departments of Immunology,undefined
[8] Protein Biochemistry and ,undefined
[9] Gene Expression Sciences,undefined
[10] Smith Kline Beecham Pharmaceuticals,undefined
来源
Nature | 1999年 / 401卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Urotensin-II (U-II) is a vasoactive ‘somatostatin-like’ cyclic peptide which was originally isolated from fish spinal cords1,2, and which has recently been cloned from man3. Here we describe the identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 (refs 4, 5) and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor. Goby and human U-II bind to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human U-II is found within both vascular and cardiac tissue (including coronary atheroma) and effectively constricts isolated arteries from non-human primates. The potency of vasoconstriction of U-II is an order of magnitude greater than that of endothelin-1, making human U-II the most potent mammalian vasoconstrictor identified so far. In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction. Furthermore, as U-II immunoreactivity is also found within central nervous system and endocrine tissues, it may have additional activities.
引用
收藏
页码:282 / 286
页数:4
相关论文
共 50 条
  • [11] Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues
    Matsushita, M
    Shichiri, M
    Imai, T
    Iwashina, M
    Tanaka, H
    Takasu, N
    Hirata, Y
    JOURNAL OF HYPERTENSION, 2001, 19 (12) : 2185 - 2190
  • [12] Discovery of New Potent Ligands at Human Urotensin-II Receptor
    Yousif, Ali Munaim
    Merlino, Francesco
    Carotenuto, Alfonso
    Limatola, Antonio
    Santicioli, Paolo
    Campiglia, Pietro
    Meini, Stefania
    Maggi, Carlo A.
    Novellino, Ettore
    Gireco, Paolo
    BIOPOLYMERS, 2013, 100 (03) : 308 - 308
  • [13] Urotensin II/GPR14 Pathway Regulates Chronic Itch in Mice
    Yang, Hua
    Zhu, Renkai
    Zhang, Wenhao
    Chen, Weiwei
    Yan, Xinrong
    Shan, Chunxu
    Xue, Shanghai
    Wang, Ruizhen
    Dai, Xiaolong
    Wang, Jinhai
    Larkin, Ciara
    Wang, Jiafu
    Meng, Jianghui
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (12) : 2546 - +
  • [14] Characterization of human urotensin-II as the most patent vasoconstrictor identified
    Douglas, SA
    Sauermelch, CF
    Coatney, R
    Eishourbagy, NA
    Aiyar, NV
    Ohlstein, EH
    Willette, RN
    CIRCULATION, 1999, 100 (18) : 567 - 568
  • [15] Discovery of new potent antagonist at urotensin-II receptor
    Sala, M.
    Auriemma, L.
    Campiglia, P.
    Monterrey-Gomez, I.
    Santicioli, P.
    Maggi, C. A.
    Rovero, P.
    Carotenuto, A.
    Novellino, E.
    Grieco, P.
    BIOPOLYMERS, 2007, 88 (04) : 604 - 604
  • [16] Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension
    Liu, Diangang
    Chen, Jing
    Wang, Jin
    Zhang, Zhongtao
    Ma, Xuemei
    Jia, Jidong
    Wang, Yu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (06) : 845 - 851
  • [17] Cloning of a novel human G-protein coupled receptor and its animal orthologues that is activated by urotensin-II, a potent vasoconstrictor
    Eishourbagy, NA
    Ames, RS
    Sarau, HM
    Chambers, J
    Aiyar, N
    Foley, JJ
    Wilson, S
    Ellis, CE
    Shabon, U
    Sechler, J
    Bergsma, DJ
    Douglas, SA
    CIRCULATION, 1999, 100 (18) : 843 - 843
  • [18] Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor
    Grieco, P
    Rovero, P
    Novellino, E
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (08) : 969 - 979
  • [19] Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist
    Bandholtz, Sebastian
    Erdmann, Sarah
    von Hacht, Jan Lennart
    Exner, Samantha
    Krause, Gerd
    Kleinau, Gunnar
    Groetzinger, Carsten
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (22) : 10100 - 10112
  • [20] Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease
    Douglas, SA
    Ohlstein, EH
    TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) : 229 - 237